{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:54:36Z","timestamp":1795107276969,"version":"4.10.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1418\/A14133"],"award-info":[{"award-number":["C1418\/A14133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Exercise may improve fatigue in multiple myeloma survivors, but trial evidence is limited, and exercise may be perceived as risky in this older patient group with osteolytic bone destruction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this Phase 2 Zelen trial, multiple myeloma survivors who had completed treatment at least 6 weeks ago, or were on maintenance only, were enrolled in a cohort study and randomly assigned to usual care or a 6-month exercise programme of tailored aerobic and resistance training. Outcome assessors and usual care participants were masked. The primary outcome was the FACIT-F fatigue score with higher scores denoting less fatigue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During 2014\u20132016, 131 participants were randomised 3:1 to intervention (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200989) or usual care (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200942) to allow for patients declining allocation to the exercise arm. There was no difference between groups in fatigue at 3 months (between-group mean difference: 1.6 [95% CI: \u22121.1\u20134.3]) or 6 months (0.3 [95% CI: \u22122.6\u20133.1]). Muscle strength improved at 3 months (8.4\u2009kg [95% CI: 0.5\u201316.3]) and 6 months (10.8\u2009kg [95% CI: 1.2\u201320.5]). Using per-protocol analysis, cardiovascular fitness improved at 3 months (+1.2\u2009ml\/kg\/min [95% CI: 0.3\u20133.7]). In participants with clinical fatigue (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917), there was a trend towards less fatigue with exercise over 6 months (6.3 [95% CI: \u22120.6\u201313.3]). There were no serious adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Exercise appeared safe and improved muscle strength and cardiovascular fitness, but benefits in fatigue appeared limited to participants with clinical fatigue at baseline. Future studies should focus on patients with clinical fatigue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>The study was registered with ISRCTN (38480455) and is completed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-020-0866-y","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T19:04:53Z","timestamp":1590001493000},"page":"187-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design"],"prefix":"10.1038","volume":"123","author":[{"given":"Dimitrios A.","family":"Koutoukidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hackshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-9351","authenticated-orcid":false,"given":"Rebecca J.","family":"Beeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Philpott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunnya","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rismani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwee L.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"866_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2410-2","volume":"16","author":"C Ramsenthaler","year":"2016","unstructured":"Ramsenthaler, C., Osborne, T. R., Gao, W., Siegert, R. J., Edmonds, P. M., Schey, S. A. et al. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 16, 427 (2016).","journal-title":"BMC Cancer"},{"key":"866_CR2","first-page":"285","volume":"15","author":"EK O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell, E. K. & Raje, N. S. Myeloma bone disease: pathogenesis and treatment. Clin. Adv. Hematol. Oncol. 15, 285\u2013295 (2017).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"866_CR3","doi-asserted-by":"publisher","first-page":"e19580","DOI":"10.1200\/jco.2014.32.15_suppl.e19580","volume":"32","author":"Q Shi","year":"2014","unstructured":"Shi, Q., Wang, X. S., Shah, N., Orlowski, R. Z., Qazilbash, M. H., Williams, L. A. et al. Prevalence of high symptom burden and its impact on functioning and quality of life in patients with multiple myeloma 3\u20139 months following autologous transplant. J. Clin. Oncol. 32, e19580\u2013e19580 (2014).","journal-title":"J. Clin. Oncol."},{"key":"866_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12185-018-2516-1","volume":"108","author":"K Suzuki","year":"2018","unstructured":"Suzuki, K., Kobayashi, N., Ogasawara, Y., Shimada, T., Yahagi, Y., Sugiyama, K. et al. Clinical significance of cancer-related fatigue in multiple myeloma patients. Int J. Hematol. 108, 580\u2013587 (2018).","journal-title":"Int J. Hematol."},{"key":"866_CR5","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.3747\/co.20.1302","volume":"20","author":"D Howell","year":"2013","unstructured":"Howell, D., Keller-Olaman, S., Oliver, T. K., Hack, T. F., Broadfield, L., Biggs, K. et al. A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr. Oncol. 20, e233\u2013e246 (2013).","journal-title":"Curr. Oncol."},{"key":"866_CR6","first-page":"Cd009075","volume":"1","author":"L Knips","year":"2019","unstructured":"Knips, L., Bergenthal, N., Streckmann, F., Monsef, I., Elter, T. & Skoetz, N. Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database Syst. Rev. 1, Cd009075 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"866_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00520-004-0668-4","volume":"12","author":"LW Jones","year":"2004","unstructured":"Jones, L. W., Courneya, K. S., Vallance, J. K., Ladha, A. B., Mant, M. J., Belch, A. R. et al. Association between exercise and quality of life in multiple myeloma cancer survivors. Support Care Cancer 12, 780\u2013788 (2004).","journal-title":"Support Care Cancer"},{"key":"866_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-319","volume":"13","author":"MJ Craike","year":"2013","unstructured":"Craike, M. J., Hose, K., Courneya, K. S., Harrison, S. J. & Livingston, P. M. Perceived benefits and barriers to exercise for recently treated patients with multiple myeloma: a qualitative study. BMC Cancer 13, 319 (2013).","journal-title":"BMC Cancer"},{"key":"866_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1188\/03.CJON.529-534","volume":"7","author":"EA Coleman","year":"2003","unstructured":"Coleman, E. A., Hall-Barrow, J., Coon, S. & Stewart, C. B. Facilitating exercise adherence for patients with multiple myeloma. Clin. J. Oncol. Nurs. 7, 529\u2013534, 540 (2003).","journal-title":"Clin. J. Oncol. Nurs."},{"key":"866_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1188\/12.ONF.468-477","volume":"39","author":"EA Coleman","year":"2012","unstructured":"Coleman, E. A., Goodwin, J. A., Kennedy, R., Coon, S. K., Richards, K., Enderlin, C. et al. Effects of exercise on fatigue, sleep, and performance: a randomized trial. Oncol. Nurs. Forum 39, 468\u2013477 (2012).","journal-title":"Oncol. Nurs. Forum"},{"key":"866_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2354.2003.00437.x","volume":"12","author":"KS Courneya","year":"2003","unstructured":"Courneya, K. S., Friedenreich, C. M., Quinney, H. A., Fields, A. L., Jones, L. W. & Fairey, A. S. A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur. J. Cancer Care 12, 347\u2013357 (2003).","journal-title":"Eur. J. Cancer Care"},{"key":"866_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-31","volume":"13","author":"L Groeneveldt","year":"2013","unstructured":"Groeneveldt, L., Mein, G., Garrod, R., Jewell, A. P., Van Someren, K., Stephens, R. et al. A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer 13, 31 (2013).","journal-title":"BMC Cancer"},{"key":"866_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1258\/135581905774414150","volume":"10","author":"R Campbell","year":"2005","unstructured":"Campbell, R., Peters, T., Grant, C., Quilty, B. & Dieppe, P. Adapting the randomized consent (Zelen) design for trials of behavioural interventions for chronic disease: feasibility study. J. Health Serv. Res. Policy 10, 220\u2013225 (2005).","journal-title":"J. Health Serv. Res. Policy"},{"key":"866_CR14","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s11999-010-1326-4","volume":"468","author":"MU Jawad","year":"2010","unstructured":"Jawad, M. U. & Scully, S. P. In brief: classifications in brief: Mirels\u2019 classification: metastatic disease in long bones and impending pathologic fracture. Clin. Orthop. Relat. Res. 468, 2825\u20132827 (2010).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"866_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2407-x","volume":"16","author":"M Heinrich","year":"2016","unstructured":"Heinrich, M., Fisher, A., Paton, B., McCourt, O., Beeken, R. J., Hackshaw, A. et al. Lifestyle in Multiple Myeloma - a longitudinal cohort study protocol. BMC Cancer 16, 387 (2016).","journal-title":"BMC Cancer"},{"key":"866_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1249\/MSS.0b013e3181e0c112","volume":"42","author":"KH Schmitz","year":"2010","unstructured":"Schmitz, K. H., Courneya, K. S., Matthews, C., Demark-Wahnefried, W., Galvao, D. A., Pinto, B. M. et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci. Sports Exerc. 42, 1409\u20131426 (2010).","journal-title":"Med Sci. Sports Exerc."},{"key":"866_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1249\/01.MSS.0000121945.36635.61","volume":"36","author":"WJ Kraemer","year":"2004","unstructured":"Kraemer, W. J. & Ratamess, N. A. Fundamentals of resistance training: progression and exercise prescription. Med Sci. Sports Exerc. 36, 674\u2013688 (2004).","journal-title":"Med Sci. Sports Exerc."},{"key":"866_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-psych-122414-033417","volume":"67","author":"W Wood","year":"2016","unstructured":"Wood, W. & Runger, D. Psychology of habit. Annu Rev. Psychol. 67, 289\u2013314 (2016).","journal-title":"Annu Rev. Psychol."},{"key":"866_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpsychores.2012.10.011","volume":"74","author":"Z Butt","year":"2013","unstructured":"Butt, Z., Lai, J. S., Rao, D., Heinemann, A. W., Bill, A. & Cella, D. Measurement of fatigue in cancer, stroke, and HIV using the functional assessment of chronic illness therapy\u2013fatigue (FACIT-F) scale. J. Psychosom. Res. 74, 64\u201368 (2013).","journal-title":"J. Psychosom. Res."},{"key":"866_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A. et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J. Clin. Oncol. 11, 570\u2013579 (1993).","journal-title":"J. Clin. Oncol."},{"key":"866_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361\u2013370 (1983).","journal-title":"Acta Psychiatr. Scand."},{"key":"866_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1164\/rccm.167.2.211","volume":"167","author":"American Thoracic S, American College of Chest P.","year":"2003","unstructured":"American Thoracic S, American College of Chest P. ATS\/ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 167, 211\u2013277 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"866_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41430-018-0335-3","volume":"73","author":"LC Ward","year":"2019","unstructured":"Ward, L. C. Bioelectrical impedance analysis for body composition assessment: reflections on accuracy, clinical utility, and standardisation. Eur. J. Clin. Nutr. 73, 194\u2013199 (2019).","journal-title":"Eur. J. Clin. Nutr."},{"key":"866_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","volume":"24","author":"D Cella","year":"2002","unstructured":"Cella, D., Eton, D. T., Lai, J. S., Peterman, A. H. & Merkel, D. E. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J. Pain. Symptom Manag. 24, 547\u2013561 (2002).","journal-title":"J. Pain. Symptom Manag."},{"key":"866_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3810\/psm.2009.06.1709","volume":"37","author":"WL Westcott","year":"2009","unstructured":"Westcott, W. L., Winett, R. A., Annesi, J. J., Wojcik, J. R., Anderson, E. S. & Madden, P. J. Prescribing physical activity: applying the ACSM protocols for exercise type, intensity, and duration across 3 training frequencies. Phys. Sportsmed. 37, 51\u201358 (2009).","journal-title":"Phys. Sportsmed."},{"key":"866_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00520-004-0734-y","volume":"13","author":"S Van Belle","year":"2005","unstructured":"Van Belle, S., Paridaens, R., Evers, G., Kerger, J., Bron, D., Foubert, J. et al. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 13, 246\u2013254 (2005).","journal-title":"Support Care Cancer"},{"key":"866_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun, V. & Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 3, 77\u2013101 (2006).","journal-title":"Qual. Res. Psychol."},{"key":"866_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ctrv.2008.11.008","volume":"35","author":"M Maddocks","year":"2009","unstructured":"Maddocks, M., Mockett, S. & Wilcock, A. Is exercise an acceptable and practical therapy for people with or cured of cancer? A systematic review. Cancer Treat. Rev. 35, 383\u2013390 (2009).","journal-title":"Cancer Treat. Rev."},{"key":"866_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00520-012-1548-y","volume":"21","author":"S Acaster","year":"2013","unstructured":"Acaster, S., Gaugris, S., Velikova, G., Yong, K. & Lloyd, A. J. Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey. Support Care Cancer 21, 599\u2013607 (2013).","journal-title":"Support Care Cancer"},{"key":"866_CR30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/bmt.2010.288","volume":"46","author":"RH Knols","year":"2011","unstructured":"Knols, R. H., de Bruin, E. D., Uebelhart, D., Aufdemkampe, G., Schanz, U., Stenner-Liewen, F. et al. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transpl. 46, 1245\u20131255 (2011).","journal-title":"Bone Marrow Transpl."},{"key":"866_CR31","doi-asserted-by":"publisher","first-page":"e0181313","DOI":"10.1371\/journal.pone.0181313","volume":"12","author":"S Persoon","year":"2017","unstructured":"Persoon, S., AMJM, Chin, Buffart, L. M., RDK, Liu, Wijermans, P., Koene, H. R. et al. Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: results from the EXIST study. PLoS ONE 12, e0181313 (2017).","journal-title":"PLoS ONE"},{"key":"866_CR32","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00520-015-2955-7","volume":"24","author":"BJ Furzer","year":"2016","unstructured":"Furzer, B. J., Ackland, T. R., Wallman, K. E., Petterson, A. S., Gordon, S. M., Wright, K. E. et al. A randomised controlled trial comparing the effects of a 12-week supervised exercise versus usual care on outcomes in haematological cancer patients. Support Care Cancer 24, 1697\u20131707 (2016).","journal-title":"Support Care Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0866-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:08:28Z","timestamp":1684602508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-0866-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,7,21]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-0866-y","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Full ethical approval was obtained by the National Research Ethics Service Committee London\u2014Queens Square Reference: 13\/LO\/1105. The study was performed in accordance with the Declaration of Helsinki. All participants provided written informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The data sets used and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Professor Kwee Yong reports grants from Celgene during the conduct of the study. The remaining authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was funded by Cancer Research UK (Programme grant no. C1418\/A14133), Cancer Research UK Development Fund and Celgene, and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and by the NIHR Oxford Biomedical Research Centre. University College London was the study sponsor. They had no role in study design, data collection, data analysis, data interpretation or the writing of the report. The corresponding author had full access to all the data in the study, and had final responsibility for the decision to submit for publication. R.J.B. is currently supported by Yorkshire Cancer Research. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}